Zynerba Pharmaceuticals, Inc.·4

May 31, 9:26 AM ET

RAPP MICHAEL 4

4 · Zynerba Pharmaceuticals, Inc. · Filed May 31, 2018

Insider Transaction Report

Form 4
Period: 2018-05-30
RAPP MICHAEL
10% Owner
Transactions
  • Purchase

    Common Stock

    2018-05-30$10.45/sh+5,885$61,4981,500,000 total
Footnotes (1)
  • [F1]Includes 80,467 shares transferred by Broadband Capital Management LLC ("BCM") to Reporting Person for no consideration. The Reporting Person was the Chairman and member of BCM.

Documents

1 file
  • 4
    s110552_form4.xmlPrimary

    4